Fortis Healthcare Ltd (FORTIS) Q3FY26 Concall Summary - Dec-2025 Qtr
Performance Overview
- The company demonstrated strong performance in Q3 FY26, overcoming the seasonal impact of festivals in key geographies, with both hospital and diagnostic businesses showing sustained growth momentum and margin expansion compared to the previous year.
- Consolidated revenues grew by 17.5% year-on-year, driven by a robust 19.4% growth in the hospital business, indicating strong operational execution and patient volumes.
- Operating EBITDA margins saw a significant improvement of 290 basis points, reaching 22.3% for the quarter, reflecting enhanced operational efficiencies and a better case mix.
- The company is actively pursuing its cluster-based inorganic growth strategy, highlighted by the acquisition of the 125-bed People Tree Hospital in Bengaluru, which is expandable to over 300 beds.
- Bed expansion plans are progressing well, with approximately 750 operational beds added so far in the financial year through a combination of acquisitions and brownfield projects.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.